NCT06339242 2024-04-01
A Study of Furmonertinib Combined With Chemotherapy in the Treatment of NSCLC With Leptomeningeal Metastasis
Jiangsu Province Nanjing Brain Hospital
Phase 2 Unknown
Clinical Trials
48 trialsNCT06332287 2024-03-27
A Study of Trilaciclib Combined With Chemotherapy in the Treatment of Advanced NSCLC With Leptomeningeal Metastasis
Jiangsu Province Nanjing Brain Hospital
Phase 2 Unknown
NCT06328049 2024-03-25
A Study of Trilaciclib Combined With Chemotherapy in the Treatment of NSCLC
Taixing People's Hospital
Phase 2 Unknown
NCT03256981 2023-12-26
HALT
Institute of Cancer Research, United Kingdom
Phase 2/3 Unknown
NCT06108726 2023-10-31
A Study of Local Envafolimab Injection Combined With Chemotherapy in Non-small Cell Lung Cancer
Northern Jiangsu People's Hospital
Phase 2 Unknown
NCT06081777 2023-10-13
MRDinS3LC
Peking University Cancer Hospital & Institute
Unknown
NCT06020352 2023-08-31
The Efficacy and Safety of KN046 Combined With Axitinib
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2/3 Unknown
NCT04811001 2023-02-21
CAPLAND
Fondazione Ricerca Traslazionale
Phase 2 Unknown
NCT04996927 2023-02-15
18F-FDG PET/CT to Evaluate pD-1 Monoclonal Antibody With First-line Chemotherapy in Advanced NSCLC
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Unknown
NCT05651269 2022-12-15
Milciclib in Combination With Gemcitabine in Advanced NSCLC
Tiziana Life Sciences LTD
Phase 2 Unknown
NCT05605613 2022-11-09
PD-1 Antibody in Addition to BACE in Patients With NSCLC: A Randomised Controlled Trial
The First Affiliated Hospital of Zhengzhou University
Phase 2/3 Unknown
NCT05547737 2022-09-21
NSCLC
Henan Cancer Hospital
Unknown
NCT05332574 2022-08-05
A Safety, Tolerability, PK and Preliminary Activity Study of GB263T in Advanced NSCLC and Other Solid Tumor
Genor Biopharma Co., Ltd.
Phase 1/2 Unknown
NCT05117658 2022-08-04
Study of HA121-28 in Patients With Non-Small Cell Lung Cancer
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase 2 Unknown
NCT05387109 2022-05-24
pcwaintrl
Tang-Du Hospital
Phase 4 Unknown
NCT05209256 2022-01-26
Alflutinib Versus Alflutinib Plus Chemotherapy for NSCLC
The First Affiliated Hospital of Henan University of Science and Technology
Phase 2/3 Unknown
NCT05065398 2022-01-21
A Phase II Clinical Trial to Evaluate HLX208 in Advanced Non-small Cell Lung Cancer Patients With BRAF V600 Mutation
Shanghai Henlius Biotech
Phase 2 Unknown
NCT05165355 2022-01-18
ATHEM
Tongji University
Phase 2 Unknown
NCT05005468 2021-08-13
CAMFA-L
Shanghai Chest Hospital
Phase 2 Unknown
NCT04874844 2021-05-10
JY025 is a First-line Treatment for EGFR Mutated NSCLC Phase II and III Clinical Trials of Efficacy and Safety
Beijing Dongfang Biotech Co., Ltd.
Phase 2/3 Unknown
NCT04826913 2021-04-01
TUMOVASC
University Hospital, Strasbourg, France
Unknown
NCT03986528 2021-02-23
Clinical Trial of Kanglaite Injection (KLTi) in Advanced Non-Small Cell Lung Cancer (NSCLC)
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Phase 4 Unknown
NCT04741633 2021-02-05
NSCLC
Fudan University
Unknown
NCT04390984 2021-01-11
Drug-drug Interaction Study of Gefitinb on Apatinib in NSCLC Patients
Jiangsu HengRui Medicine Co., Ltd.
Phase 1 Unknown
NCT04575415 2020-10-20
BELLA
Guangdong Association of Clinical Trials
Unknown
NCT04506242 2020-09-09
Camrelizumab With Apatinib as Neoadjuvant Therapy for Participants With Resectable Non-Small Cell Lung Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Unknown
NCT04413227 2020-06-02
A Phase Ib Study With Pegylated Recombinant Human Endostatin in Advanced / Metastatic NSCLC or Other Solid Tumors
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1 Unknown
NCT04199559 2019-12-16
Evaluating Combination Therapy Using Autologous Dendritic Cells Pulsed With Antigen Peptides and Nivolumab for Subjects With Advanced Non-Small Cell Lung Cancer
Henan Cancer Hospital
Phase 1/2 Unknown
NCT04164745 2019-11-15
Efficacy and Safety Study of Anlotinib With Pembrolizumab in Adults With Programmed Cell Death-Ligand 1 (PD-L1)-Positive Treatment-naïve Non-small Cell Lung Cancer
Peking Union Medical College Hospital
Phase 2 Unknown
NCT04007835 2019-07-05
Anlotinib Hydrochloride Combined With EGFR-Tyrosine Kinase Inhibitor (TKI) in Treating Advanced NSCLC Patients With Acquired Resistance to EGFR-TKI
Guangdong Association of Clinical Trials
Phase NA Unknown
NCT03428022 2019-04-04
AFLC
Shenzhen People's Hospital
Phase 3 Unknown
NCT03799601 2019-01-10
ALTER-L013
Tongji Hospital
Phase 4 Unknown
NCT03656393 2018-09-04
RCTACSCNSCLC
Shenzhen People's Hospital
Phase 3 Unknown
NCT03453307 2018-03-05
Drug Sensitivity Correlation Between Patient-Derived Organoid Model and Clinical Response in NSCLC Patients
K2 Oncology, Inc.
Unknown
NCT03416231 2018-01-31
Apatinib Plus Docetaxel in Advanced Non-squamous Non-small Cell Lung Cancer(NSCLC)
Affiliated Hospital of North Sichuan Medical College
Phase 2 Unknown
NCT03269162 2017-09-14
Postoperative NSCLC Treated With Integrated Medicine Base on Circulating Tumor Cell Detection
Shanghai University of Traditional Chinese Medicine
Phase 3 Unknown
NCT02404675 2017-07-28
INCREASE
Betta Pharmaceuticals Co., Ltd.
Phase 4 Unknown
NCT02975609 2016-11-29
Phase II Trial of SBRT Compared With Conventional Radiotherapy for Oligometastatic Non-Small Cell Lung Cancer
Shanghai Chest Hospital
Phase 2 Unknown
NCT02778893 2016-05-20
Conmana Combined With Thalidomide to Treat NSCLC
Henan Provincial People's Hospital
Phase 4 Unknown
NCT02631460 2015-12-16
S1 vs.Pemetrexed Plus Carboplatin in Patients With EGFR Wild Type Stage IIIB or IV Nonsquamous NSCLC
Sun Yat-sen University
Phase 2 Unknown
NCT01998425 2015-07-31
Circulating Fibrocytes in Non-small Cell Lung Cancer.
Chang Gung Memorial Hospital
Unknown
NCT02387086 2015-03-12
Gefitinib Combined With Thalidomide to Treat NSCLC
Shaanxi Provincial People's Hospital
Phase 2/3 Unknown
NCT02140333 2015-02-12
Erlotinib 100mg or 150mg in Treating EGFR Mutated NSCLC
The First Affiliated Hospital of Guangzhou Medical University
Phase 3 Unknown
NCT02272127 2014-10-22
Study of Chemotherapy Plus Icotinib to Treat EGFR Mutation-positive Non-small-cell Lung Cancer
Nanfang Hospital, Southern Medical University
Phase 2 Unknown
NCT01861223 2014-02-25
Afatinib Plus Nimotuzumb for NSCLC
Samsung Medical Center
Phase 1/2 Unknown
NCT01100827 2013-12-11
A Retrospective Molecular Epidemiology Study in Singapore Patients With Advanced Non Small Cell Lung Cancer (NSCLC) of Adenocarcinoma Histology to Assess Epidermal Growth Factor Receptor (EGFR) Mutation Status
National University Hospital, Singapore
Unknown
NCT01932229 2013-08-30
An Open Label Study of BIBW 2992/Afatinib in Advanced Non-Small Cell Lung Cancer Patients Pre-treated With Erlotinib or Gefitinib
Sheba Medical Center
Phase 2 Unknown
NCT01105182 2010-04-16
FACPT
The First Affiliated Hospital of Guangzhou Medical University
Unknown